17 research outputs found
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients
Clinical features and natural history of coronavirus disease 2019 (COVID-19) differ widely among different countries and during different phases of the pandemia. Here, we aimed to evaluate the case fatality rate (CFR) and to identify predictors of mortality in a cohort of COVID-19 patients admitted to three hospitals of Northern Italy between March 1 and April 28, 2020. All these patients had a confirmed diagnosis of SARS-CoV-2 infection by molecular methods. During the study period 504/1697 patients died; thus, overall CFR was 29.7%. We looked for predictors of mortality in a subgroup of 486 patients (239 males, 59%; median age 71 years) for whom sufficient clinical data were available at data cut-off. Among the demographic and clinical variables considered, age, a diagnosis of cancer, obesity and current smoking independently predicted mortality. When laboratory data were added to the model in a further subgroup of patients, age, the diagnosis of cancer, and the baseline PaO2/FiO2 ratio were identified as independent predictors of mortality. In conclusion, the CFR of hospitalized patients in Northern Italy during the ascending phase of the COVID-19 pandemic approached 30%. The identification of mortality predictors might contribute to better stratification of individual patient risk
Patologia cardiovascolare nell'infezione da HIV/AIDS: valutazione del rischio e sua prevenzione
L’infezione da HIV, causa dell’AIDS, è una patologia che è ormai entrata nella quarta decade della sua storia. Mentre negli anni ’80 del secolo scorso questa condizione portava inevitabilmente alla morte nel volgere di pochi anni, oggi, grazie alla terapia antiretrovirale altamente attiva (HAART), assume i caratteri di una infezione cronica ben controllabile nel tempo. Tale trattamento però, sebbene fonte di enormi vantaggi, è ben lungi da risolvere completamente il problema. I pazienti che con la terapia riescono a sopprimere la viremia hanno un’aspettativa di vita simile alle persone non infette dal virus, ma possono andare incontro ad un invecchiamento accentuato o accelerato. Tale condizione si accompagna ad una maggiore incidenza di comorbidità non AIDS relate, che si manifestano anche in presenza di livelli di linfociti CD4+ ottimali. Tra di esse sono comprese le malattie cardiovascolari. Vi è ormai un considerevole corpo di letteratura che mostra come queste ultime siano più frequenti tra le persone affette da HIV. In precedenza si riteneva che questo fosse dovuto principalmente agli effetti collaterali dismetabolici della HAART, ma oggi sappiamo che hanno un ruolo anche l’infiammazione cronica, l’azione nociva delle proteine virali e la maggiore prevalenza dei fattori di rischio cardiovascolari tradizionali tra gli HIV positivi. Ad oggi ci si interroga ancora su come effettuare una corretta prevenzione. Gli score clinici di rischio cardiovascolare a nostra disposizione sembrano tutti sottostimare il rischio in questa categoria di pazienti, per cui si valuta l’impiego dell’imaging, come per il calcium score e la valutazione ecografica dello spessore intima-media delle arterie carotidi. Il presente lavoro comprende uno studio retrospettivo caso-controllo effettuato sui pazienti con HIV in cura presso la U.O.C. Malattie Infettive di Pisa. Sono stati analizzati e messi a confronto coi relativi controlli 31 pazienti che hanno avuto un IMA dal 2000 al 2016, al fine di ottenere informazioni riguardo alla loro età , sesso, fattori di rischio cardiovascolari tradizionali, stato immunologico e farmaci utilizzati. I parametri legati all’infezione da HIV non hanno mostrato differenze statisticamente rilevanti tra i due gruppi: CD4+ basali (p=0,1355), viremia basale (p=0,4722), farmaci utilizzati e in particolare l’esposizione cumulativa ai PI e agli NRTI (p=0,8452 e 0,5732) e CD4+ al momento dell’evento (p=0,9495). Al contrario lo studio dei fattori di rischio cardiovascolare tradizionali ha mostrato una differenza significativa tra casi e controlli: in particolare il fumo (p=0,02), l’ipertensione (p=0,052), il colesterolo HDL (p=0,0166) ed i trigliceridi (p=0,0221)
COVID-19 CT Scan Lung Segmentation: How We Do It
: The National Health Systems have been severely stressed out by the COVID-19 pandemic because 14% of patients require hospitalization and oxygen support, and 5% require admission to an Intensive Care Unit (ICU). Relationship between COVID-19 prognosis and the extent of alterations on chest CT obtained by both visual and software-based quantification that expresses objective evaluations of the percentage of ventilated lung parenchyma compared to the affected one has been proven. While commercial applications for automatic medical image computing and visualization are expensive and limited in their spread, the open-source systems are characterized by not enough standardization and time-consuming troubles. We analyzed chest CT exams on 246 patients suspected of COVID-19 performed in the Emergency Department CT room. The lung parenchyma segmentation was obtained by a threshold-based method using the open-source 3D Slicer software and software tools called "Segment Editor" and "Segment Quantification." For the three main characteristics analyzed on lungs affected by COVID-19 pneumonia, a specifical densitometry value range was defined: from - 950 to - 700 HU for well-aerated parenchyma; from - 700 to - 250 HU for interstitial lung disease; from - 250 to 250 HU for parenchymal consolidation. For the well-aerated parenchyma and the interstitial alterations, the procedure was semi-automatic with low time consumption, whereas consolidations' analysis needed manual interventions by the operator. After the chest CT, 13% of the sample was admitted to intensive care, while 34% of them to the sub-intensive care. In patients moved to intensive care, the parenchyma analysis reported a higher crazy paving presentation. The quantitative analysis of the alterations affecting the lung parenchyma of patients with COVID-19 pneumonia can be performed by threshold method segmentation on 3D Slicer. The segmentation could have an important role in the quantification in different COVID-19 pneumonia presentations, allowing to help the clinician in the correct management of patients
Long-lasting consequences of Coronavirus disease 19 pneumonia: a systematic review
Introduction: Coronavirus Disease 19 (Covid-19) is an infectious disease caused by the newly discovered severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We have plenty of data about the clinical features of the disease's acute phase, while little is known about the long-term consequences on survivors. Evidence acquisition: We aimed to review systematically emerging evidence about clinical and functional consequences of Covid-19 pneumonia months after hospital discharge. Evidence synthesis: Current evidence supports the idea that a high proportion of Covid-19 survivors complain of symptoms months after the acute illness phase, being fatigue and reduced tolerance to physical effort the most frequently reported symptom. The strongest association for these symptoms is with the female gender, while disease severity seems less relevant. Respiratory symptoms are associated with a decline in respiratory function and, conversely, seem to be more frequent in those who experienced a more severe acute pneumonia. Current evidence highlighted a persistent motor impairment which is, again, more prevalent among those survivors who experienced a more severe acute phase of the disease. Additionally, the persistence of symptoms is a primary determinant of mental health outcome, with anxiety, depression, sleep disturbances, and post-traumatic stress symptoms being commonly reported in Covid-19 survivors. Conclusions: Current literature highlights the importance of a multidisciplinary approach to Coronavirus Disease 19 since the sequelae appear to involve different organs and systems. Given the pandemic outbreak's size, this is a critical public health issue: a better insight on this topic should inform clinical decisions about the modalities of follow-up for Covid-19 survivors
A Novel Block Imaging Technique Using Nine Artificial Intelligence Models for COVID-19 Disease Classification, Characterization and Severity Measurement in Lung Computed Tomography Scans on an Italian Cohort
Computer Tomography (CT) is currently being adapted for visualization of COVID-19 lung damage. Manual classification and characterization of COVID-19 may be biased depending on the expert's opinion. Artificial Intelligence has recently penetrated COVID-19, especially deep learning paradigms. There are nine kinds of classification systems in this study, namely one deep learning-based CNN, five kinds of transfer learning (TL) systems namely VGG16, DenseNet121, DenseNet169, DenseNet201 and MobileNet, three kinds of machine-learning (ML) systems, namely artificial neural network (ANN), decision tree (DT), and random forest (RF) that have been designed for classification of COVID-19 segmented CT lung against Controls. Three kinds of characterization systems were developed namely (a) Block imaging for COVID-19 severity index (CSI); (b) Bispectrum analysis; and (c) Block Entropy. A cohort of Italian patients with 30 controls (990 slices) and 30 COVID-19 patients (705 slices) was used to test the performance of three types of classifiers. Using K10 protocol (90% training and 10% testing), the best accuracy and AUC was for DCNN and RF pairs were 99.41\ub15.12%, 0.991 (p<0.0001), and 99.41\ub10.62%, 0.988 (p<0.0001), respectively, followed by other ML and TL classifiers. We show that diagnostics odds ratio (DOR) was higher for DL compared to ML, and both, Bispecturm and Block Entropy shows higher values for COVID-19 patients. CSI shows an association with Ground Glass Opacities (0.9146, p<0.0001). Our hypothesis holds true that deep learning shows superior performance compared to machine learning models. Block imaging is a powerful novel approach for pinpointing COVID-19 severity and is clinically validated
Correlation of Pre- and Post-radio-chemotherapy MRI Texture Features With Tumor Response in Rectal Cancer
Background/aim: The present study aimed to investigate radiomics features derived from magnetic resonance imaging (MRI) in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy (CRT). Patients and methods: We retrospectively evaluated data of 53 patients (32 males, 21 females) with T3/T4 or N+ rectal cancer who underwent MRI before and after CRT. Twenty-seven texture radiomics features were extracted from regions of interest, delimiting the tumor on T2-weighted images. Results: All 27 radiomics features extracted before CRT showed a statistically significant association with the tumor regression grade (TRG) (p<0.05), whereas, after CRT, only the Cluster Prominence value was the only variable to predict TRG (p=0.037, r=0.291). Conclusion: All 27 features extracted before CRT were able to predict response to CRT and Cluster Prominence continued to be statistically significant even after CRT. The impact of radiomics features derived from MRI could be further investigated in patients with locally advanced rectal cancer
Computed Tomography findings of COVID-19 pneumonia in Intensive Care Unit-patients
BACKGROUND: In December 2019, a cluster of unknown etiology pneumonia cases occurred in Wuhan, China leading to identification of the responsible pathogen as SARS-coV-2. Since then, the coronavirus disease 2019 (COVID-19) has spread to the entire world. Computed Tomography (CT) is frequently used to assess severity and complications of COVID-19 pneumonia. The purpose of this study is to compare the CT patterns and clinical characteristics in intensive care unit (ICU) and non-ICU patients with COVID-19 pneumonia.DESIGN AND METHODS: This retrospective study included 218 consecutive patients (136 males; 82 females; mean age 63\ub115 years) with laboratory-confirmed SARS-coV-2. Patients were categorized in two different groups: (a) ICU patients and (b) non-ICU inpatients. We assessed the type and extent of pulmonary opacities on chest CT exams and recorded the information on comorbidities and laboratory values for all patients.RESULTS: Of the 218 patients, 23 (20 males: 3 females; mean age 60 years) required ICU admission, 195 (118 males: 77 females, mean age 64 years) were admitted to a clinical ward. Compared with non-ICU patients, ICU patients were predominantly males (60% versus 83% p=0.03), had more comorbidities, a positive CRP (p=0.04) and higher LDH values (p=0.008). ICU patients' chest CT demonstrated higher incidence of consolidation (p=0.03), mixed lesions (p=0.01), bilateral opacities (p<0.01) and overall greater lung involvement by consolidation (p=0.02) and GGO (p=0.001).CONCLUSIONS: CT imaging features of ICU patients affected by COVID-19 are significantly different compared with non-ICU patients. Identification of CT features could assist in a stratification of the disease severity and supportive treatment
Extracorporeal membrane oxygenation (ECMO) in COVID-19 patients: a pocket guide for radiologists
During the coronavirus disease 19 (COVID-19) pandemic, extracorporeal membrane oxygenation (ECMO) has been proposed as a possible therapy for COVID-19 patients with acute respiratory distress syndrome. This pictorial review is intended to provide radiologists with up-to-date information regarding different types of ECMO devices, correct placement of ECMO cannulae, and imaging features of potential complications and disease evolution in COVID-19 patients treated with ECMO, which is essential for a correct interpretation of diagnostic imaging, so as to guide proper patient management
Comparison of deep learning, radiomics and subjective assessment of chest CT findings in SARS-CoV-2 pneumonia
Purpose
Comparison of deep learning algorithm, radiomics and subjective assessment of chest CT for predicting outcome (death or recovery) and intensive care unit (ICU) admission in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Methods
The multicenter, ethical committee-approved, retrospective study included non-contrast-enhanced chest CT of 221 SARS-CoV-2 positive patients from Italy (n\u202f=\u202f196 patients; mean age 64\u202f\ub1\u202f16\u202fyears) and Denmark (n\u202f=\u202f25; mean age 69\u202f\ub1\u202f13\u202fyears). A thoracic radiologist graded presence, type and extent of pulmonary opacities and severity of motion artifacts in each lung lobe on all chest CTs. Thin-section CT images were processed with CT Pneumonia Analysis Prototype (Siemens Healthineers) which yielded segmentation masks from a deep learning (DL) algorithm to derive features of lung abnormalities such as opacity scores, mean HU, as well as volume and percentage of all-attenuation and high-attenuation (opacities > 12200 HU) opacities. Separately, whole lung radiomics were obtained for all CT exams. Analysis of variance and multiple logistic regression were performed for data analysis.
Results
Moderate to severe respiratory motion artifacts affected nearly one-quarter of chest CTs in patients. Subjective severity assessment, DL-based features and radiomics predicted patient outcome (AUC 0.76 vs AUC 0.88 vs AUC 0.83) and need for ICU admission (AUC 0.77 vs AUC 0.0.80 vs 0.82). Excluding chest CT with motion artifacts, the performance of DL-based and radiomics features improve for predicting ICU admission.
Conclusion
DL-based and radiomics features of pulmonary opacities from chest CT were superior to subjective assessment for differentiating patients with favorable and adverse outcomes